Tax Reform in This Election Year: It's Not Likely
Which Credit Card Rewards Does the IRS Care About?
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) engages in the development, production, and sale of a range of generic and branded pharmaceuticals, biogenerics, and active pharmaceutical ingredients (APIs) worldwide.
The long-term chart shows a stock that has never been in a bear market.
The recent resistance line is merely a pause in its long-term upward march, and it was broken by heavy buying in April. Teva ran to a new all-time high above $55, and then pulled back on profit-taking.
Buy TEVA now -- it's a cornerstone health care stock that should be part of every high-quality portfolio.
Next: Technical Trade #4
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
